SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Trevi Therapeutics to participate in upcoming September conferences

Trevi Therapeutics says it will participate in upcoming September conferences, highlighting its investigational therapy Haduvio for chronic cough in patients with idiopathic pulmonary fibrosis and non-IPF.

TRVI

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories